SEARCH

SEARCH BY CITATION

References

  • 1
    Sledge GW Jr, Roth BJ. Cisplatin in the management of breast cancer [review]. Semin Oncol 1989; 16: 1105.
  • 2
    Sledge GW Jr, Loehrer PJ Sr, Roth BJ, Einhorn LH. Cisplatin as first-line therapy for metastatic breast cancer. J Clin Oncol 1988; 18114.
  • 3
    Wander HE, Rauschning W, Meyer D, Achterrath W, Nagel GA. Phase II study with etoposide in previously untreated advanced breast cancer. Cancer Chemother Pharmacol 1989; 2613.
  • 4
    Cocconi G, Bisagni G, Bacchi M, Boni C, Bartolucci R, Ceci G, et al. Cisplatin and etoposide as first-line chemotherapy for metastatic breast cancer. J Clin Oncol 1991; 6649.
  • 5
    Peters WP, Stuart A, Klotman M, Gilbert C, Jones RB, Shpall EJ, et al. High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support: a clinical and pharmacologic study. Cancer Chemother Pharmacol 1989; 23: 3773.
  • 6
    Cox EB, Burton GV, Olsen GA, Vugrin D. Cisplatin and etoposide: an effective treatment for refractory breast carcinoma. Am J Clin Oncol 1989; 12: 536.
  • 7
    Martin M, Diaz-Rubio, Casado A, Santabarbara S, Veja J, Adrover E. Carboplatin: an active drug in metastatic breast cancer. J Clin Oncol 1992; 10: 4437.